Why Is p53 Acetylated?  by Prives, Carol & Manley, James L.
Cell, Vol. 107, 815–818, December 28, 2001, Copyright 2001 by Cell Press
MinireviewWhy Is p53 Acetylated?
to bind DNA (Gu and Roeder, 1997; Sakaguchi et al.,Carol Prives1 and James L. Manley
Department of Biological Sciences 1998; Espinosa and Emerson, 2001). This observation
extended numerous previous studies showing thatColumbia University
New York, New York 10027 phosphorylation, antibody binding, or deletion of its C
terminus, as measured by EMSA, stimulates specific
DNA binding by p53. Based on such observations, it
was assumed that the C terminus of p53 serves as aRecent studies suggest that acetylation of the p53
tumor suppressor protein is not important for its DNA negative regulator of the central core domain’s se-
quence-specific DNA binding activity. That hypothesis,binding activity, as was previously thought. We dis-
cuss here a number of theories as to how this modifi- however, was recently challenged by Espinosa and Em-
erson (2001), who showed that while acetylation of p53cation may serve to regulate the protein’s functions.
by p300 can stimulate its ability to bind to a short oligo-
nucleotides containing a binding site from the p21 pro-The p53 tumor suppressor protein is a sequence-spe-
cific transcription factor that responds to a wide variety moter, it has no effect on the ability of p53 to bind its
sites within the p21 promoter when they are present inof stress signals in order to regulate processes such as
cell cycle, cell death, and DNA repair. When p53 protein a much longer DNA molecule. Moreover, these authors
also showed that a p53 protein deleted of its C terminusbecomes stabilized (as a result of release from its nega-
tive regulator Mdm2), a number of genes are either in- is actually less effective in interacting with the p21 pro-
moter when present in either naked or chromatinizedduced or repressed. P53 is extensively phosphorylated
and it is likely that phosphorylation plays multiple roles DNA. Espinosa and Emerson, using a somewhat more
physiological assay, have thus not only challenged thein regulating its functions. Nevertheless, phosphoryla-
tion is not the only mode by which p53 can be modified. long-held notion that the p53 C terminus serves an auto-
inhibitory role, but also provided evidence that acetyla-In 1997, Gu and Roeder made the unexpected observa-
tion that p53 can be acetylated by the p300 histone tion has no significant effect on the interaction of p53
with DNA. Supporting this observation, Barlev et al.acetyltransferase (HAT) on several lysine residues at its
extreme COOH terminus. This was surprising because (2001) used a chromatin immunoprecipitation (ChIP)
assay to compare wild-type p53 or p53 containing sev-it had been assumed that histones are the main, if not
sole, substrates of p300. In fact, it was soon discovered eral mutated acetylation sites (K320R, K373R, K381R,
and K382R) and showed that both forms of p53 bindthat another histone acetylase, P/CAF, can also acet-
ylate p53 (Sakaguchi et al., 1998 Liu et al., 1999). These similarly to the p21 promoter in U2OS cells. Based on
these and others’ results, it thus now seems unlikelyobservations were made considerably more biologically
relevant when a number of groups (Sakaguchi et al., that acetylation of p53 has a significant effect on its
ability to bind to sites within promoters of target genes1998; Liu et al., 1999; Gottifredi et al., 2001; Ito et al.,
2001; Pearson et al., 2000) showed that p53 can be such as p21.
Co-activator recruitment? So if not to modulate DNAacetylated in vivo in response to a variety of cellular stress
signals. P300/CBP and pCAF acetylate p53 at different binding, what is the function of p53 acetylation/deacety-
lation? The answer, unfortunately, is not completelysites; p300/CBP at K372, K373, K381, and K382 within its
extreme COOH terminus, and PCAF at K320 within a linker clear, and more than one possibility has been suggested
by data that is at least partly contradictory. Two studies,region that joins the sequence-specific DNA binding and
tetramerization domains. Figure 1 shows the domains perhaps surprisingly, suggest that acetylation of p53
may not play a significant role in p53-dependent tran-of p53 and approximate locations of these different acet-
ylation sites. These observations raise two questions: scriptional activation. Nakamura et al. (2000) performed
transient transfection assays in p53 null cells with ex-Why does p53 become acetylated, and how is p53’s
acetylation regulated? Although many intriguing possi- pression vectors encoding p53 containing simultane-
bilities have been put forth, unfortunately the situation ously mutated lysines at positions 372, 373, 381, and
is not yet clear. 382 (the p300/CBP sites) to ala, asp, or his together with
What Are the Functional Consequences a p21-based reporter plasmid. Unexpectedly, all three
of Acetylating p53? mutant p53 proteins activated reporter gene expression
DNA binding? The first attempts to address the signifi- to the same extent as wild-type p53, arguing that the
cance of p53 acetylation employed the well-trodden identities of these residues, and hence their acetylation
path of examining the DNA binding properties of p53 status, are not important for transcriptional activation.
by using the electrophoretic mobility shift assay (EMSA). Espinosa and Emerson (2001) used an elegant in vitro
This assay measures the ability of p53 to bind to short transcription assay to demonstrate that a pre-assem-
oligonucleotides containing the sequence of one of sev- bled chromatin template containing the p21 promoter
eral known p53 binding sites. By this approach, it was and far upstream p53 binding sites was transcriptionally
shown that that acetylation of p53 at sites within its silent when incubated in HeLa nuclear extract, but that
COOH or linker regions functions to stimulate its ability transcription could be strongly and synergistically acti-
vated by preincubation of the template with purified p53
and p300. Remarkably, they found that wild-type p531 Correspondence: clp3@columbia.edu
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ences in the details of these transfections and those of
Nakamura et al. (e.g., Barlev et al. used different mu-
tants, most frequently one containing lys to arg changes
at 320, the P/CAF site, as well as 373, 381, and 382),
but it is not clear if these can explain the difference in
results. Barlev et al. also provided evidence, in the form
of ChIP assays and GST pull-downs, that p53 acetylation
is required first for efficient recruitment in vivo of CBP
and the PCAF complex to promoter regions and second
for interaction of p53 with these factors in vitro. These
findings, at least with CBP, are particularly hard to rec-
oncile with the in vitro functional assays of Espinosa and
Figure 1. Domains and Modifications of the p53 Protein Emerson (unless there is a difference in the behaviors of
Functional domains of p53, including the activation region (yellow), CBP and p300, which would be unprecedented in these
PXXP-containing region (red), sequence-specific DNA binding core
types of assays). Especially puzzling is how, in the studydomain (dark blue), tetramerization domain (orange), and basic regu-
of Barlev et al., a single residue mutation (K382R) signifi-latory region (violet), are indicated below the protein. Acetylation
cantly reduced binding to CBP (and PCAF), but the moresites (turquoise circles marked “A”) are indicated below acetylases
(P/CAF and p300/CBP) known to acetylate these receptive sites in extensive mutation analyzed by Espinosa and Emerson
vitro. N-terminal sites that are phosphorylated in response to stress (see above) had no effect on the ability of p53 to interact
signals (orange circles marked “P”) are indicated above the diagram. functionally with p300 to activate transcription in vitro.
The Mdm2 interaction region is shown in blue. It should be noted as well that if p53 acetylation is re-
quired for its function in transactivation, it is not suffi-
cient since Gottifredi et al. (2001) showed that whenand a mutant derivative containing lysines 370, 372, 373,
DNA replication is blocked, acetylated p53 accumulates380, and 382 changed to arg (which, as predicted, could
but is transcriptionally inert.not be acetylated by p300) displayed identical levels of
So while it is now quite apparent that acetylation is notactivation. Suggesting a possible mechanism for this
required for DNA binding by p53, different experimentalactivation, ChIP experiments revealed extensive p53
approaches have provided contradictory conclusions
and p300-dependent histone acetylation spanning the
as to whether this modification is necessary for tran-
p21 promoter (see Figure 2).
scriptional activation by p53. How can these differing
The above studies seem to make a strong case for
results be reconciled? The best current guess is that
the conclusion that p53 acetylation does not play a di-
p53 acetylation might modestly enhance transcriptional
rect role in the protein’s ability to function as a transcrip-
activation, and perhaps only under certain specific cir-
tional activator. But possibly throwing a wrench into this cumstances, but it is not absolutely required. Moreover,
picture are results of Barlev et al. (2001), which argue since the studies mentioned used various versions of
that p53 acetylation is in fact important for transcrip- p53 with mutated lysines, we cannot know if such mu-
tional activation, functioning to facilitate recruitment of tants yield proteins that are structurally or functionally
the coactivators p300/CBP and the PCAF complex. similar to one that carries unacetylated lysines at these
Transient transfections with wild-type and mutant p53- positions. It is also not yet known is whether there may
expressing plasmids showed modest but clear reduc- be additional acetylation sites on p53 that are also nec-
tions in expression of either a p21-based reporter or the essary for its functions, or perhaps whether a specific
endogenous p21 gene. There were a number of differ- pattern of acetylation and phosphorylation may be re-
quired. Such possibilities may need to be explored be-
fore a clear picture emerges.
Cellular localization? How else might acetylation influ-
ence p53 activity? It may, directly or indirectly, affect
subcellular localization, although here the available data
is also confusing. Nakamura et al. (2000) found in their
transfection experiments that the p53 lys mutants they
studied overaccumulated 2-fold relative to wild-type
p53 and localized to some degree in the cytoplasm.
Evidence was presented that this resulted from a defect
in Mdm2-mediated ubiquitination and turnover, but not
in transport to the cytoplasm. By contrast, however,
Barlev et al. (2001) did not detect either increased accu-
Figure 2. Roles of Acetylation in Transcriptional Regulation by p53 mulation or cytoplasmic localization of p53 mutants in
their transfections.Association of p53 (blue spheres) with chromatin is not affected by
its state of acetylation, but p53-dependent alterations in chromatin Despite these disparities, another link between p53
structure by histone acetylation and subsequent recruitment of the acetylation and cellular localizaton has been uncovered.
transcriptional machinery (general transcription factors, mediator Pearson et al. (2000) showed that PML, a ring finger
and RNA polymerase II) are facilitated by interactions with acet-
containing protein that localizes to discrete nuclear bod-ylases, and possibly by acetylation of p53 itself (acetyl groups on
ies (NBs), is induced by ras and this leads to its colocali-p53 and histones are indicated by red circles). Deacetylases serve
zation to NBs along with p53 and CBP. They foundto repress p53-mediated transcription, likely by returning chromatin
to a repressed state. that PML overexpression also results in the concomitant
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acetylation of p53 at K320 and K382. Whether acetyla- less than observed with wild-type p53. One explanation
tion of p53 is required for its colocalization to or its for this is that the mutant nonacetylatable p53 is less
function within NBs remains to be determined. efficient at recruiting hSir2, and hence in repressing tran-
P53 Deacetylation: Shutting Down or Recruitment scription. In any event, these studies link hSir2 and its
to Repression Targets? interesting connections to general cellular metabolism
It is often speculated that upon moderate levels of DNA (via its NAD dependence) and life span to control of p53.
damage, p53 causes cells to arrest to allow the damage How do histone deacetylase complexes silence p53-
to be repaired before cells resume proliferation. If so, activated expression? This is likely to result at least in
we need to consider ways that p53 might be turned off part from deacetylation of nucleosomes in the vicinity
once it is no longer needed. In this regard, a speculative of the target promoter. But certainly deacetylation of
function for p53 acetylation might be that it helps to other factors, including p53 itself, may contribute. Do
mark a p53-activated promoter for subsequent inactiva- some complexes, for example the mSin3A complex,
tion. By this view, chromatin-bound p53 recruits coacti- serve specifically to allow p53 to actively repress tran-
vators such as p300/CBP and PCAF, which function at scription of some genes, while others, such as the PID/
least in part by acetylating nucleosomal histones (Figure MTA2 or Sir2 complexes, serve the function of resetting
2). Acetylation of p53 might be a mechanism to recruit the chromatin back to ground state? If p53 acetylation
deacetylases to eventually dampen expression. Indeed, (which presumably occurs rapidly) serves primarily to
there are increasing lines of evidence that interactions recruit deacetylases, what delays their association with
of p53 with deacetylases play a role in p53 regulation. p53 until needed? Could compartmentalization (such as
Murphy et al. (1999) showed that p53 can associate recruitment of acetylated p53 by PML into NBs) ensure
with mSin3A, a corepressor previously reported to be that it remains acetylated as required? Future experi-
involved in transcriptional repression of several genes, ments will hopefully reveal the answers to some of these
and that this is necessary for p53 to recruit HDAC1. questions.
They showed that the p53-mSin3A-HDAC1 association Regulating p53 Acetylation
is necessary for p53 to repress at least two of its targets, Given the as yet incomplete understanding of the mean-
namely MAP4 and stathmin. Additionally, Juan et al. ing(s) of p53 acetylation, it might be somewhat prema-
(2000) found that overexpression of HDACs can down- ture to discuss ways by which this process is regulated.
regulate p53 transcriptional activity, and that HDAC1 Nevertheless, there are some interesting and possibly
can directly interact with p53 in vitro. Luo et al. (2000) revealing results that support the likely importance of
identified another p53 interacting protein that they this modification. First, phosphorylation of p53, known
named PID (previously identified as MTA2) that was to activate its functions, may facilitate its ability to be
shown to be present in deacetylase complexes con- acetylated. Sakaguchi et al.(1998) showed that N-termi-
taining HDAC1. Thus, p53 can enter into at least two nal peptides of p53 phosphorylated at certain key resi-
HDAC1 containing complexes. When and how it func- dues were effective in blocking the ability of PCAF to
tions in these complexes is unclear. Contributing to the acetylate p53. They proposed that phosphorylated p53
potential importance of deacetylases in regulating p53 is more effective in recruiting HATs than unphosphory-
is the observation that rendering cells hypoxic causes lated p53 protein. Their conclusion is supported by re-
p53 to interact somewhat more efficiently with mSin3A, ports showing that phosphorylation of p53 at N-terminal
which may make p53 incapable of inducing a number residues indeed increases its interactions with p300
of its downstream target genes (Koumenis et al., 2001). (Lambert et al., 1998; Dumaz and Meek, 1999; Dornan
Now to add more weight to the significance of the and Hupp, 2001). Second, in contrast to phosphoryla-
relationship between p53 and deactylases, two groups tion, Mdm2 blocks the ability of p300 to acetylate p53
(Vaziri et al., 2001; Luo et al.,2001) have discovered that in vivo and in vitro (Kobet et al., 2000; Ito et al., 2001).
p53 can interact with another histone deacetylase, the Thus, acetylation of p53 is stimulated by its positive
NAD-dependent enzyme hSir2. HSir2 (aka Sir2 or
regulator (phosphorylation) and abrogated by its nega-
SIRT1) is the human homolog of the S. cerevesiae Sir2
tive regulator (Mdm2). This supports the idea that, how-
protein, known to function in chromatin silencing at telo-
ever it works, acetylation of p53 is likely to be critical
meres and elsewhere, and to play a role in determining
for it to function as a tumor suppressor. A perhaps over-
life span (reviewed by Guarente, 2000). Both Vaziri et
simplified model depicting the possible roles of acetyla-al. and Luo et al. showed that transient overexpression
tion and deacetylation in p53 function is shown in Figureof catalytically active hSir2 abrogates p53-mediated ac-
2. Although discrepancies still exist, and many questionstivation of target promoters in cotransfection assays,
remain to be answered, the subject of p53 acetylationand also provided evidence that the two proteins inter-
is a fascinating one and sure to keep our attention welleact in vivo and in vitro. Whether p53 acetylation en-
into the future.hances this association was not tested directly. How-
ever, certain functional data are consistent with the view Selected Reading
that p53 acetylation might facilitate Sir2 function. Luo
et al. presented data with a p53 acetylation-defective Barlev, N.A., Liu, L., Chehab, N.H., Mansfield, K., Harris, K.G., Hala-
zonetis, T.D., and Berger, S.L. (2001). Mol. Cell 8, 1243–1254.mutant (the same quintuple lys to arg mutant used by
Dornan, D., and Hupp, T.R. (2001). EMBO J. 2, 139–144.Espinosa and Emerson in the in vitro assays described
above) and showed first that the mutant p53 can indeed Dumaz, N., and Meek, D.W. (1999). EMBO J. 18, 7002–7010.
activate reporter gene expression in their assays. Inter- Espinosa, J.M., and Emerson, B.M. (2001). Mol. Cell 8, 57–69.
estingly, activation was again reduced by coexpression Gottifredi, V., Shieh, S.-Y., Taya, Y., and Prives, C. (2001). Proc. Natl.
Acad. Sci. USA 98, 1036–1041.of hSir2, but the degree of inhibition was substantially
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